Kavikondala, Sushma
Haeussler, Katrin
Wang, Xuan
Bausch-Jurken, Mary T.
Nassim, Maria
Mishra, Nitendra Kumar
Malmenäs, Mia
Sharma, Pawana
Van de Velde, Nicolas
Green, Nathan
Beck, Ekkehard
Funding for this research was provided by:
Moderna
Article History
Received: 1 December 2023
Accepted: 30 January 2024
First Online: 18 March 2024
Declarations
:
: Mary T. Bausch-Jurken, Nicolas Van de Velde, and Ekkehard Beck are employees of Moderna, Inc., and hold stock/stock options in the company. Katrin Haeussler, Xuan Wang, Maria Nassim, Nitendra Kumar Mishra, Mia Malmenäs, and Pawana Sharma are employees of ICON plc, a clinical research organization paid by Moderna, Inc., to conduct the study. Sushma Kavikondala is a former employee of ICON plc. Nathan Green is an independent consultant employed at University College of London, and was paid by Moderna, Inc., to conduct aspects of this study.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.